Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Valeant

Stock Watch: Full Approval And Surrogates Await Clinical Validation

When surrogate endpoints are used for accelerated approvals in advance of more compelling functional outcomes, how long should the duration of the confirmatory studies be?

Stock Watch Clinical Trials

Bausch + Lomb Turns To Familiar Face As CEO, Brent Saunders

Saunders will oversee the consumer health, pharma and medtech eye health and vision care specialist, returning to where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.

Executive Changes Business Strategies

Bausch + Lomb Taps A Familiar Face, Brent Saunders, As Next CEO

Saunders will oversee the eye specialist, returning to the firm where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.

Leadership Companies

As Quantity Of Cannabis IND Applications Grows, US FDA Has ‘Quality Considerations’ Guidance

Research targeting botanicals generally, as well as cannabis, as potential APIs is increasing, a factor in CDER’s publication of cannabis trials guidance, the FDA’s Norman Birenbaum says in an interview.

Cannabidiol CBD Guidance Documents
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register